Top Story

Symbicort yields lower risk for asthma exacerbations than budesonide

September 27, 2016

Read the Perspective from Jay M. Portnoy, MD

Symbicort and budesonide monotherapy showed a comparable risk profile for serious asthma-related events in adolescents and adults with moderate-to-severe asthma, while the combination therapy yielded a lower risk for exacerbations, according to recently published data.

“Current guidelines for the management of asthma suggest that inhaled glucocorticoids should be used as initial controller therapy, with a [long-acting beta-agonist (LABA)] then added if symptoms remain uncontrolled or increase in severity,” Stephen P. Peters, MD, PhD, acting section chief of pulmonary, critical care, allergy and immunologic medicine at Wake Forest Baptist Health, and colleagues wrote. “Although LABAs have been an available treatment option for asthma since 1990, questions remain regarding the safety of this drug class.”

Americas becomes first region declared free of measles

September 27, 2016
The Americas became the first WHO region to be declared free of measles after going 14 years without an endemic case. The announcement was made today during the annual…

Q&A: Keeping nonimmunizing families in practices

September 27, 2016
According to a recent study in Pediatrics, the percentage of pediatricians who reported parents refusing vaccines for their children rose from 74.5% in 2006 to 87% in…
In the Journals Plus

Prenatal Tdap vaccination more effective than postpartum immunization

September 27, 2016
Tdap vaccination from 27 to 36 weeks’ gestation was 85% more effective than postpartum vaccination at preventing pertussis in infants aged younger than 8 weeks…
In the Journals

Dengvaxia increases risk for dengue virus in low-transmission areas

September 27, 2016
The dengue virus vaccine Dengvaxia, now available in six countries, may increase disease severity in locations with lower infection rates and in younger children…
More News Headlines »
Original Article

Success Rates of Conventional Versus Endoscope-Assisted Probing for Congenital Nasolacrimal Duct Obstruction in Children 12 Years and Younger

Journal of Pediatric Ophthalmology and Strabismus, September/October 2016, Volume 53 Issue 5
To compare the success rates for congenital nasolacrimal duct obstruction (CNLDO) treated with conventional probing…
More »

Infectious Diseases: May 2015

Keck School of Medicine of USC and Pediatric Annals

With improved diagnostic tools and increasingly rapid turnaround on results, we have never lived at a better time to…
More »
PAS 2016

PAS 2016

Meeting News Coverage

VIDEO Treating eating disorders in adolescents

May 14, 2016
More »